The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson’s Disease: What We Know and Where to Go
Shuzhen Zhu(Hubei Provincial Center for Disease Control and Prevention), Qing Wang(Shaoxing People's Hospital), Yuqi Luo(Zhujiang Hospital), Wucheng Yang(Zhujiang Hospital), Xiaoyan Xu(Zhujiang Hospital), Yang Guo(Peking University), Hualing Li(Zhujiang Hospital), Xingfang Guo(Henan University of Engineering), Xiaobo Wei(Zhujiang Hospital), Bin Deng(Zhujiang Hospital)
Cited by 34
Related Papers
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
|Frontiers in Aging Neuroscience|2018|378
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
|Brain|2021|262
Microglia as modulators of exosomal alpha-synuclein transmission
|Cell Death and Disease|2019|206
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
|Brain|2020|167
New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
|Frontiers in Aging Neuroscience|2018|111